Physician profile
Remil Simon
NPI 1881156149
$2,568.23
in general payments reported to CMS, 2019-2025
12 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $99.99 · 2021: $230 · 2022: $671 · 2023: $1,100 · 2024: $215 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,370.80 | 2021-2025 | Clareon, Clareon Panoptix Pro, Hydrus Microstent |
| Sight Sciences, INC. | $173.64 | 2022-2024 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $156.21 | 2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Oyster Point Pharma, INC. | $150.00 | 2022 | |
| Genentech USA, INC. | $147.27 | 2023 | Vabysmo |
| Tarsus Pharmaceuticals, INC. | $112.19 | 2024-2025 | Xdemvy |
| Genentech, INC. | $104.72 | 2022 | |
| Allergan, INC. | $99.99 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $92.07 | 2023 | Tecnis Iol, Tecnis Simplicity |
| Mallinckrodt Hospital Products INC. | $81.36 | 2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $53.69 | 2022 | |
| Bausch & Lomb Americas INC. | $26.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Remil Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.